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PUTTING CRAVING INTO CONTEXT: EFFECTS OF PERCEIVED SMOKING 
OPPORTUNITY ON THE NEURAL RESPONSE TO CIGARETTE CUE EXPOSURE 
 
Stephen Jeffrey Wilson, BS 
 
University of Pittsburgh, 2004 
 
 
Recent years have seen the emergence of research applying functional neuroimaging to the study 
of cue-elicited drug craving.  This research has begun to identify a distributed system of brain 
activity during drug craving.  Functional magnetic resonance imaging (fMRI) was used to 
examine the effects of smoking expectancy on the neural response to neutral (e.g., roll of tape) 
and smoking-related (holding a cigarette) stimuli in male cigarette smokers deprived of nicotine 
for 8 hours.  As predicted, several brain regions exhibited differential activation during cigarette 
versus neutral cue exposure.  Moreover, instructions about smoking opportunity affected cue-
elicited activation in several regions.  These results highlight the importance of perceived drug 
availability in the neurobiological response to drug cues.   
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1.0 INTRODUCTION 
 
 
Drug abuse and addiction are major societal problems, with economic costs that 
exceed $100 billion in the US alone (Holland & Mushinski, 1999).  Two broad classes of 
research have been used extensively in the study of drug addiction: basic research aimed 
at identifying the neural and pharmacological mechanisms underlying drug addiction in 
animals, and research aimed at investigating the cognitive and affective processes 
associated with addiction in humans.  More recently, researchers have employed 
convergent cognitive and neuroscientific techniques in order to provide for a more 
comprehensive understanding of addiction.  In particular, the neurobiological substrata of 
the distorted motivational and decision-making processes pathognomonic of addiction 
have been of great interest to researchers interested in advancing a multidimensional 
account of human drug addiction. 
1.1 Functional Neuroimaging 
 
 
Functional neuroimaging techniques, such as single photon emission tomography 
(SPECT), positron emission tomography (PET), and functional magnetic resonance 
imaging (fMRI), provide powerful tools for the in vivo examination of neural functioning 
(Stern & Silbersweig, 2001).  Rapid technological advances in functional neuroimaging 
techniques and the resultant enhancement in ability to localize the neural circuitry 
subserving cognitive processes such as perception, attention, emotion, memory, language, 
and motor function, have greatly advanced our understanding of normal brain 
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functioning.  Importantly, clinical researchers are increasingly using these techniques to 
examine brain dysfunction in a variety of disorders, such as addiction (Kaufman, 2001). 
Functional neuroimaging offers the critical advantage of providing a means for 
investigating the loci of anomalous function associated with symptomatology.  One 
prominent method for investigating the craving associated with addiction is to expose 
drug-addicted individuals to drug-associated stimuli and assess concomitant changes 
across multiple response systems (self-report, cognitive performance and physiological 
measures).  Exposure to drug cues reliably produces a variety of subjective and cognitive 
sequelae in substance dependent individuals (Carter & Tiffany, 1999).  In particular, cue 
exposure elicits heightened self-reported substance use desire, one index of the drug 
acquisitive motivational state henceforth referred to as craving (Baker, Morse, & 
Sherman, 1986; Sayette et al., 2000).  Only recently have researchers begun to apply 
functional neuroimaging techniques to the study of drug cue reactivity. 
1.2 Searching for the Neural Basis of Craving: Current Limitations 
 
 
Worden and Schneider (1995) outline three major stages in the neural mapping of 
cognitive processing: (1) determining the number, location, and stability (i.e., 
reproducibility within and between subjects) of regions activated by a particular process; 
(2) replicating and investigating topological characteristics of regional activation; (3) 
determining stimulus- and task-based differential activation within replicated regions.  
Neuroimaging studies of cue-elicited craving have thus far operated at the first and, to a 
lesser extent, second stages of this framework, seeking primarily to localize and replicate 
regions demonstrating preferential activation by drug-associated stimuli and to determine 
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whether such regions are stable across addicted populations (e.g., individuals addicted to 
cocaine vs. heroin).  Within the past decade, a rapidly growing body of functional 
neuroimaging studies has adopted the traditional cue-reactivity procedure as a means for 
elucidating the neural bases of craving.  Thus far, a distributed network of brain regions 
has been linked to cue-elicited craving, with the amygdala, anterior cingulate cortex 
(ACC), orbitofrontal cortex (OFC), and dorsolateral prefrontal cortex (DLPFC) being the 
most commonly reported loci of activation in 23 neuroimaging studies of cue-reactivity 
(Wilson, Sayette, & Fiez, 2004; see Figure 1).   
Although the above regions have been most frequently associated with human 
drug craving, they unfortunately have been inconsistently activated across studies.  
Indeed, the multifaceted nature of craving has posed significant challenges to precise 
localization and characterization of its constituent neural substrates.  For example, 
significant cue-elicited activation of OFC – a region assuming a prominent role in 
contemporary neurobiological models of craving (Goldstein & Volkow, 2002; Jentsch & 
Taylor, 1999; London, Ernst, Grant, Bonson, & Weinstein, 2000) – has been reported by 
only 8 of 22 studies (Bonson et al., 2002; Brody et al., 2002; Grant et al., 1996; Kilts, 
Gross, Ely, & Drexler, 2004; Myrick et al., 2004; Tapert et al., 2003; Wang et al., 1999; 
Wrase et al., 2002; OFC activity not assessed by Maas et al., 1998).  Results are similarly 
discrepant for the amygdala (8 of 22 studies) (Bonson et al., 2002; Childress et al., 1999; 
Due, Huettel, Hall, & Rubin, 2002; Grant et al., 1996; Kilts, 2001; Kilts et al., 2004; 
Schneider et al., 2001; Tapert et al., 2003; not assessed by Modell & Mountz, 1995), 
DLPFC (9 of 23) (Bonson et al., 2002; Due et al., 2002; Garavan et al., 2000; George et 
al., 2001; Grant et al., 1996; Grüsser et al., in press; Maas et al., 1998; Tapert, Brown, 
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Baratta, & Brown, 2004; Wrase et al., 2002), and ACC (13 of  23) (Brody et al., 2002; 
Childress et al., 1999; Daglish et al., 2001; Garavan et al., 2000; Grüsser et al., in press; 
Kilts, 2001; Kilts et al., 2004; Myrick et al., 2004; Tapert et al., 2004; Tapert et al., 2003; 
Wexler et al., 2001; Wrase et al., 2002).  To date, conflicting results have been largely 
ignored or vaguely attributed to inter-study methodological variance (Bonson et al., 2002; 
George et al., 2001; Hommer, 1999; Schneider et al., 2001).  No framework has yet been 
offered to account for the contradictory pattern of results observed across studies.      
1.3 Contextual Modulation of Cue-Elicited Craving 
 
 
1.3.1 Behavioral Evidence.  Recent data contradict the prevailing view that cue-elicited 
craving is an entirely stimulus-bound response.  Instead, craving may be modulated by 
the context associated with cue presentation (Baker et al., 1986).  One contextual factor 
that significantly influences the response to drug cues is whether or not participants 
anticipate actually using the drugs to which they are being exposed (i.e., perceived drug 
use opportunity; Wertz & Sayette, 2001b).  When instructed that drugs are available for 
consumption during an experiment, drug users report substantially higher craving when 
presented with drug cues than when instructed that drugs are not available for an 
extended period of time or until after the experiment has concluded (Carter & Tiffany, 
2001; Droungas, Ehrman, Childress, & O'Brien, 1995; Juliano & Brandon, 1998). 
Affective (Carter & Tiffany, 2001; Sayette et al., 2003) and cognitive processes (Juliano 
& Brandon, 1998; Wertz & Sayette, 2001a) are also differentially influenced by drug cue 
presentation as a function of whether or not drug use is expected.  Similarly, 
physiological responses thought to reflect arousal, such as skin conductance (Carter & 
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Tiffany, 2001), heart rate (Lazev, Herzog, & Brandon, 1999), and asymmetrical frontal 
electrocortical activity (Zinser, Fiore, Davidson, & Baker, 1999), are heightened in 
contexts predictive of impending drug use.  Many of these effects transfer to arbitrary 
stimuli (e.g., colored cards) that come to be associated with the opportunity, or lack 
thereof, to consume (Dols, Willems, van den Hout, & Bittoun, 2000; Field & Duka, 2002; 
Lazev et al., 1999).   
 
1.3.2 Treatment-Seeking Status: A Proxy for Perceived Drug Use Opportunity.  To date, 
neuroimaging studies of craving have not explicitly manipulated perceived drug-use 
opportunity, making it difficult to assess the degree to which regions observed in 
previous studies may respond to perception of drug availability as opposed to other 
factors affecting craving.  However, it has been suggested that treatment status affects 
perceived drug use opportunity (Wertz & Sayette, 2001b).  Specifically, those seeking 
treatment are likely to resist consuming drugs (thus drug use opportunity is absent).  In 
contrast, actively using addicts are likely to perceive the opportunity to consume 
immediately after, if not during, the experiment.  Individuals enrolled in drug treatment 
programs do appear to exhibit responses consistent with low expectations of drug 
availability, while those not in treatment exhibit responses consistent with high 
expectations of drug availability (Wertz & Sayette, 2001b).  It also is possible that 
treatment status may affect neurobiological responses to drug cues.    
If treatment-seeking status does affect neural activity elicited by drug cues, such 
effects would be most readily apparent in neural regions capable of integrating 
motivational/affective (e.g., current desires) and cognitive (e.g., knowledge of the 
probability and means of acquiring desired outcomes) information.  Prefrontal cortex 
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(PFC), an area thought to be largely responsible for supporting such flexibility 
(Groenewegen & Uylings, 2000; Krawczyk, 2002), has not been well investigated in the 
context of human drug craving.  However, an emerging literature suggests that the neural 
basis for adaptive processing of incentive stimuli is mediated by specific regions of PFC 
(Balleine & Dickinson, 1998; Krawczyk, 2002; Wallis, Dias, Robbins, & Roberts, 2001).  
The two PFC regions that have received the most attention vis-à-vis craving are OFC 
(London et al., 2000; Volkow & Fowler, 2000) and DLPFC (Anton, 1999; Bonson et al., 
2002; Grant et al., 1996).  OFC is thought to contribute to goal-directed behavior via the 
assessment of the motivational significance of stimuli and the selection of behavior to 
obtain desired outcomes (Rolls, 2000).  OFC has extensive connections with the striatum 
as well as limbic regions (e.g., amygdala) and, as a result, is well situated to integrate the 
activity of several limbic and subcortical areas associated with motivational behavior and 
reward processing (Groenewegen & Uylings, 2000).   
DLPFC also contributes to regulatory processing under conditions requiring the 
integration of cognitive and motivationally-relevant information (Watanabe, Hikosaka, 
Sakagami, & Shirakawa, 2002), possibly by integrating information provided by OFC 
and other regions with which it is connected (Groenewegen & Uylings, 2000).  DLPFC 
plays a central role in reward-processing and decision-making, particularly when 
information must be maintained over a delay or when multiple sources of information 
must be used to guide behavior (Krawczyk, 2002).       
Taken together, converging evidence suggests that treatment-seeking status may 
influence the neurobiological responses to drug cues, particularly in specific subregions 
of PFC.  Interestingly, of 23 neuroimaging studies of cue-elicited craving, 12 exclusively 
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recruited individuals actively using drugs (Bonson et al., 2002; Brody et al., 2004; Brody 
et al., 2002; Due et al., 2002; Garavan et al., 2000; George et al., 2001; Grant et al., 1996; 
Maas et al., 1998; Myrick et al., 2004; Tapert et al., 2004; Tapert et al., 2003; Wang et 
al., 1999); in contrast, 10 studies exclusively recruited individuals seeking or receiving 
treatment for drug addiction (Braus et al., 2001; Childress et al., 1999; Daglish et al., 
2001; Grüsser et al., in press; Kilts, 2001; Modell & Mountz, 1995; Schneider et al., 
2001; Sell et al., 1999; Wexler et al., 2001; Wrase et al., 2002)1.  Thus, variability across 
these studies may reflect, in part, an unappreciated effect of drug use expectations on cue-
elicited neural activity (Meyer, 2000; Volkow et al., 2003).   
Table 1 presents DLPFC and OFC activation in studies categorized according to 
whether or not participants were seeking drug treatment at the time of study 
participation2.  Studies were included if they exposed participants to drug-related cues.  
Cue exposure could be accomplished through a variety of methods (e.g., holding a 
cigarette, viewing a video of cocaine use).  As shown, activation of DLPFC and OFC has 
been found in the majority of studies in which participants were active drug users.  In 
contrast, studies employing treatment-seeking participants have, with few exceptions, 
failed to find significant activation of DLPFC and OFC.  Interestingly, the incidence of 
significant activation of other regions commonly associated with craving (e.g., amygdala, 
ACC) is approximately equally distributed across studies employing actively using and 
treatment-seeking drug users, suggesting that the effect of treatment status are most 
robust in these subdivisions of PFC.  
                                                 
1 The sample recruited by Kilts et al. (2004) was heterogeneous with respect to treatment-seeking status, 
consisting of both cocaine-dependent women undergoing outpatient treatment and those not receiving 
treatment. 
2 Brody et al. (2004) did not examine cue main effects (e.g., drug cue versus netural cue) in DLPFC and 
OFC and was therefore excluded from Table 1.  
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  Increased cue-elicited activation of DLPFC and OFC among active users may 
reflect explicit representation of this expectancy (by OFC) and the generation and 
maintenance of behavioral goals aimed at obtaining drug reward (by DLPFC) (Anton, 
1999; Bonson et al., 2002; Goldstein & Volkow, 2002).  OFC neurons are more active 
during delay periods when rewards are expected than when no such reward is expected 
(Hikosaka & Watanabe, 2000).  Similarly, DLPFC neurons encode reward expectancy 
during a delay (Hikosaka & Watanabe, 2000; Wallis & Miller, 2003; Watanabe et al., 
2002).  Moreover, delay activity of DLPFC neurons has been shown to predict 
subsequent behavioral responses in rewarded tasks (Wallis & Miller, 2003).  Lesions of 
both OFC (Rolls, 2000) and of rat prelimbic cortex (Balleine & Dickinson, 1998), the 
functional homologue of the non-human primate and human DLPFC, impair the 
acquisition and modification of behavior guided by contingencies between responses and 
outcomes, suggesting that these regions are critical for the control of goal-directed 
behavior.    
 
1.3.3  Remaining Questions.  Studies examining neurobiological responses to drug cues 
thus far have yielded a complex and contradictory pattern of findings.  It is clear that 
variables relating to participant characteristics, such as treatment status, are critical 
factors that may reconcile otherwise discrepant findings.  It has been proposed that 
constraints on the perceived drug use opportunity held by participants may underlie such 
effects.  Nonetheless, this factor has not been explicitly manipulated in extant studies and, 
as such, the degree to which perceived opportunity and other factors related to treatment-
seeking status account for these data awaits direct investigation.   
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Moreover, there are several possible mechanisms by which drug use expectancy 
may influence neurobiological responses to drug cue presentation in addition to those 
raised above (i.e., goal-directed processing under conditions in which drug use is 
expected).  For example, those seeking treatment may be motivated to maintain 
abstinence and may therefore attempt to inhibit cue-elicited craving, perhaps via the use 
of techniques acquired during treatment (Wertz & Sayette, 2001b).  It is quite possible 
that such efforts to inhibit would produce a different pattern of neural activation 
compared to the eager anticipation of future drug use.  Further, it is likely that perceived 
drug use opportunity produces different effects in different contexts.  For instance, the 
pattern of neural activity elicited by drug cues in drug-addicted individuals entering drug 
treatment may significantly differ from that produced in actively using addicts that are 
explicitly told that they cannot consume for a long period of time.  In the former case, 
individuals do not intend to consume drugs because they are trying to quit (i.e., they are 
abstinence-seeking), while in the latter instance, individuals desire to seek and consume 
drugs, but are prevented from doing so by situational constraints (i.e., they are 
abstinence-avoidant) (Tiffany, 1990).  
 
1.4  Specific Aims of the Proposed Research 
 
 
The objective of the proposed research was to address this important gap in our 
knowledge.  Specifically, fMRI was employed to investigate contextual modulation of 
functional activation in the neural circuitry implicated in human drug craving.  The 
specific aims of the proposed study were as follows: 
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Aim 1: To identify brain regions that process drug cues independent of perceived 
drug use opportunity.  
Hypothesis 1:  Responses in anterior cingulate and amygdala elicited by drug-
related stimuli are not dependent upon perceived drug use opportunity.  The present study 
sought to further characterize the neural response to drug cues in humans.  It was 
predicted that drug cue exposure would significantly increase activity in anterior 
cingulate and amygdala relative to presentation of neutral objects.  Further, it was 
proposed that cue-elicited responses in these regions would not be modulated by 
perceived drug-use opportunity.  
Aim 2: To demonstrate that perceived drug use opportunity modulates the neural 
response to drug-associated stimuli. 
Hypothesis 2: Contextual modulation of the neural response to presented drug 
cues will be localized to ventral/orbitofrontal cortex (OFC) and dorsolateral prefrontal 
cortex (DLPFC).  It was proposed that perception of drug availability modulates the 
evaluation of drug-associated stimuli.  Specifically, it was suggested that these effects are 
localized to OFC and DLPFC.  Based upon a review of the literature, it was predicted that 
subjects who anticipate proximal drug use would exhibit significantly greater activation 
in these PFC subregions. 
 
2.0 METHOD 
 
2.1 Participants 
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 Twenty-two right-handed, male, native English speaking cigarette smokers 
participated in the experiment (mean age = 24.4 years, SD = 4.9).  All participants 
reported smoking between 20-40 cigarettes per day for at least 24 continuous months 
(mean cigarettes/day = 21.6, SD = 2.7).  Participants were recruited through 
advertisements in local newspapers.  Exclusionary criteria included dependence on any 
drug other than nicotine or caffeine, illiteracy, or medical conditions that ethically 
contraindicated nicotine administration.  Written informed consent was obtained from all 
participants.  Participants were paid for participation, and all procedures were approved 
by the Institutional Review Board of the University of Pittsburgh.  Data from two 
participants were excluded from all analyses because of excessive head motion during 
scanning; subsequent analyses are reported on the remaining 20 participants.  
 Participants were invited to participate in a 2 hour study.  They were randomly 
assigned to one of two experimental conditions: 1) half of the participants were told that 
they would be able to smoke during a break at the midpoint of the experimental session 
(Instructed-Yes; n = 10), 2) the other half were instructed that they could not smoke 
during the experimental session and would have to wait approximately two hours before 
smoking (Instructed-No; n = 10).  Age, number of cigarettes smoked per day, number of 
quit attempts, and years of education were similar across instructed smoking expectancy 
conditions (ps > 0.05, see Table 1).    
2.2 Cue Exposure Procedure 
 
 
 Participants completed two cue exposure runs, during which they were asked to 
hold and look at stimuli that were designed to elicit either (a) minimal changes in craving 
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(i.e., neutral objects) or (b) stimuli designed to elicit robust increases in craving (one of 
their own cigarettes).  Each cue exposure run began with a 48 second resting baseline 
epoch during which no objects were held.  After the initial rest period, the first cue of the 
run was placed in the left hand of the participant and instructions identifying the object 
were delivered over an intercom system.  After a period of 74 seconds, the object was 
removed.  A second resting baseline epoch lasting 74 seconds followed removal of the 
object.  Subsequently, the second cue of the run and identifying instructions were 
presented and the object was held for a period of 74 seconds.  During the first cue 
exposure run, participants were presented with a small yellow notepad (neutral object) 
and a white plastic golf ball (neutral object).  This run served to allow participants to 
acclimate to the task.  During the second run, participants were presented with a roll of 
black electrical tape (neutral object) and one of their cigarettes (craving-eliciting object).   
2.3 Urge rating assessment 
 
 
 Participants verbally rated their urge to smoke on a scale from 0 (labeled 
“absolutely no urge to smoke at all”) to 100 (labeled “strongest urge to smoke I’ve ever 
experienced).  Urge ratings were provided immediately before the start of each of the two 
cue exposure runs.  Participants also rated their urge at the completion of each run.  Thus, 
a total of 4 urge ratings were obtained from each participant (Urge #1 – Urge #4).  
Ideally, each of these ratings would have been obtained during stimulus exposure (i.e., 
while participants were holding each object); however, it was decided to assess urge 
preceding each run (Urge #1 and Urge #3) rather than during exposure to the first object 
of the run in order to avoid eliciting unwanted neural activity and because of practical 
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constraints (e.g. difficulty communicating with participants over scanner noise).  Urge 
ratings obtained at the completion of each run (Urge #2 and #4) occurred after fMRI data 
acquisition had terminated and while participants were still holding the second object of 
the run.     
2.4 Procedure 
 
 
Participants who responded to the advertisements completed a preliminary 
screening interview over the phone.  Eligible participants visited the lab for three 
sessions: a more thorough screening assessment (Session 1), a session in which 
abstinence instructions were provided (Session 2), and the experimental session (Session 
3).  Session 2 and Session 3 were conducted eight hours apart on the same day.  During 
Session 1, participants provided an expired air carbon monoxide (CO) sample (CO #1), 
which was used to verify smoking status.  Session 2 occurred eight hours prior to the 
experimental session, during which subjects returned to the laboratory to smoke one of 
their cigarettes.  After smoking the cigarette, a second CO sample was obtained (CO #2) 
to provide a baseline for comparison to levels obtained at the start of the experimental 
session.  Subsequently, all participants were instructed not to drink alcohol or use tobacco 
products or other drugs for 8 hours prior to arriving at the laboratory to participate in the 
experiment.  Participants then presented their pack of cigarettes and lighter to the 
experimenter and were permitted to leave the laboratory.  Experimental sessions were 
scheduled to begin between 4 pm and 6 pm.  To check compliance with deprivation 
instructions, participants reported the last time they smoked a cigarette and a third CO 
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sample was obtained (CO #3).  For the third CO assessment, samples exceeding half of 
the CO #2 and/or 16 parts per million resulted in exclusion from the study.   
Immediately before scanning began, participants were given instructions 
regarding whether they would be permitted to smoke during the experimental session.  As 
all participants were informed that the experimental session would last for 2 hours, 
Instructed-No participants therefore expected a significant delay before having the 
opportunity to smoke (see also Juliano & Brandon, 1998).   For Instructed-Yes 
participants, smoking expectancy instructions were delivered in a room located in close 
proximity to that housing the MRI scanner by an experimenter standing in front of a sign 
designating the room as a “smoking area for research purposes” (actual smoking took 
place outside, see below).  This was done to enhance the likelihood that these participants 
would anticipate the opportunity to smoke almost immediately after cigarette cue 
exposure (i.e., that they would be able to smoke after a short trip down the hall).  At this 
point, participants completed the first of two cue presentation runs.  Participants then 
completed a guessing task involving monetary gains or losses (Delgado, Nystrom, Fissell, 
Noll, & Fiez, 2000) for approximately 45 minutes (data from this task are not presented 
herein).   
Subsequently, participants completed the second cue presentation run.  While 
holding the cigarette during the second run, Instructed-Yes were told that in 40 seconds, 
they would be removed from the scanner and would be permitted to immediately smoke 
the cigarette they were holding.  Instructed-No participants were told that they would be 
removed from the scanner in 40 seconds, but would not be able to smoke the cigarette 
they were holding.  Following self-reported craving assessment, all participants were 
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removed from the scanner for a brief break (about 5 minutes) and those participants told 
that they would be permitted to smoke were escorted outside where they were permitted 
to smoke a cigarette at their own pace.  Afterwards, participants were returned to the 
scanner to complete approximately 45 additional minutes of the guessing task (data not 
presented) and were then debriefed. 
2.5 FMRI Data Acquisition and Processing 
 
 
 Participants were scanned using a conventional 1.5 T GE Signa whole-body 
magnet and standard radio frequency coil.  A structural series of 36 contiguous oblique-
axial slices (3.75 x 3.75 x 3.8 mm voxels) parallel to the AC-PC line was collected using 
a standard T1-weighted pulse sequence.  Functional images were acquired in the same 
plane as the structural series with coverage limited to the 20 center slices using a T2*-
weighted one-shot spiral pulse sequence (TE=35 ms, TR=1500 ms, FOV=24 cm, flip 
angle = 70°).  FMRI data analysis was conducted using the Neuroimaging Software 
package (NIS 3.5), developed at the University of Pittsburgh and Princeton University, as 
implemented in the Functional Imaging Software Widgets graphical computing 
environment (Fissell et al., 2003).  Following reconstruction, single-subject data was 
corrected for motion using Automated Image Registration (AIR 3.08; Woods, Cherry, & 
Mazziotta, 1992) and adjusted for drift between runs.  After stripping to remove skull, 
structural images from each participant were co-registered to a common reference 
anatomy (Woods, Mazziotta, & Cherry, 1993).  In order to form a composite data set for 
group-level statistical analyses, functional images were transformed into the same space, 
globally mean-normalized to minimize differences in image intensity between 
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participants, and smoothed using a three-dimensional Gaussian filter (6-mm FWHM) to 
account for between-subject anatomical differences.  Group-based statistical images were 
visualized and transformed into standard stereotaxic space (Talairach & Tournoux, 1988) 
using the Analysis of Functional NeuroImages software package (AFNI 2.6; Cox, 1996). 
2.6 FMRI Data Analysis 
 
 
 The set of co-registered functional data was used in all voxel-based statistical 
analyses, although individual subject data were inspected in order to confirm consistency 
of results across subjects.  FMRI signal averaged over the final 48 seconds of cue 
exposure for each object was the blood oxygen level-dependent (BOLD) response of 
interest.  The initial 26 seconds of each object exposure epoch was removed to allow for 
stabilization of responses corresponding to instruction delivery.  The first cue exposure 
run served to allow participants to acclimate to holding object while in the MRI scanner 
and was not included in analyses.   
To isolate regions of interest, a voxel-wise mixed-model ANOVA was performed 
with instruction set (Instructed-Yes, Instructed-No) as a between-subjects variable and 
cue (neutral, cigarette) as a repeated measures variable.  One objective of this analysis 
was the localization of regions that exhibited preferential activation by the cigarette cue 
(main effect of cue).  For cue main effects, the voxel-wise significance threshold was set 
at p < .005 (uncorrected).  Main effect regions of activation comprised of fewer than five 
contiguous voxels were not considered significant in order to reduce the risk of false 
positives (Forman et al., 1995).   
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In addition to examining cue main effects, the primary analytic objective was the 
identification of regions that demonstrated differential activation during cue exposure as 
a function of perceived drug use opportunity (instruction set by cue interaction).  Given 
the exploratory nature of this study and the findings from a prior review pointing to 
DLPFC and OFC as regions most influenced by perceived drug use opportunity (Wilson 
et al., 2004), a liberal voxel-wise alpha of p < .01 (uncorrected) and spatial extent 
threshold of three or more contiguous voxels was chosen for detecting an interaction 
between instruction set and cue.  There were no specific a priori hypotheses regarding 
interaction effects occurring outside of DLPFC and OFC and, because the chosen 
threshold does not provide adequate protection against type I errors across the whole 
brain, activations falling beyond these regions are reported for completeness but are not a 
focus of discussion.   
 
 
 
3.0 RESULTS 
 
4.1 Self-reported Urge 
 
 
 A 2 (instruction set) X 4 (time) repeated measures analysis of variance 
(ANOVA), with the four urge ratings as a repeated measures variable, revealed a main 
effect of time, F(3, 54) = 24.9, p < .001.  Trend analysis revealed significant linear [F(1, 
18) = 46.5, p < .001] and cubic [F(1, 18) = 9.7, p = 0.006].  As shown in Figure 3, urge 
ratings rose over time, with inflection points at Urge #2 and Urge #3.  The instruction set 
by time interaction was not significant.  However, based upon the observed effect size 
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(Cohen’s f < 0.05) and size of the present sample, power to detect this interaction at α = 
0.05 was quite low (< 0.10).  
4.2 Imaging data 
 
 
 Main Effect of Cue.  Regions exhibiting a main effect of cue are summarized in 
Table 3 and depicted in Figure 4.  Significantly greater BOLD signal during cigarette 
relative to neutral cue exposure was detected in the left superior (BA 19) and middle (BA 
18) occipital gyrus, right posterior cingulate gyrus (BA 23), left inferior parietal cortex 
(BA 39) a large cluster in the anterior cingulate extending to medial frontal gyrus (BA 
32/8), bilateral superior/middle temporal cortex (BA 21), right cuneus (BA 18), and right 
fusiform gyrus.  Significantly greater activation during neutral relative to cigarette cue 
presentation was observed in bilateral middle and posterior cingulate gyrus (BA 24/31), 
left precuneus (BA 7), bilateral thalamus, bilateral lentiform nucleus (primarily globus 
pallidus), right middle occipital gyrus (BA 19), a large region encompassing the left 
lingual gyrus and adjacent cuneus (BA 17/18/19), and left insula (BA 13).      
 Instruction Set by Cue Interaction.  A significant instruction set by cue interaction 
was observed in multiple foci (see Table 4 and Figure 5a), including bilateral dorsolateral 
prefrontal cortex (DLPFC; middle/inferior frontal gyri, BA 9/46), two right-lateralized 
regions in rostrolateral prefrontal cortex (RLPFC; middle frontal gyrus, BA 10), 
ventromedial prefrontal cortex (VMPFC; medial frontal gyrus, BA 10), left ventrolateral 
prefrontal cortex (VLPFC; inferior frontal gyrus, BA 47), left cuneus (BA 19), right 
precentral gyrus (BA 6), right superior (BA 22) and left middle temporal gyrus (BA 21), 
left inferior/middle occipital gyrus (BA 19/18), and left parahippocampal gyrus.  In order 
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to determine the nature of the interaction for these regions, the effects of cue were 
examined separately for each instructional group (see Figure 5b).  In DLPFC, VLPFC, 
superior temporal gyrus, occipital gyrus, and parahippocampal gyrus, significantly less 
activation was found for Instructed-Yes participants during cigarette relative to neutral 
cue exposure, whereas BOLD signal did not significantly differ between stimulus 
conditions for Instructed-No participants.  In VMPFC, precentral gyrus, and middle 
temporal gyrus, signal was significantly greater during cigarette relative to neutral cue 
exposure for Instructed-Yes participants, while there was no difference between cue types 
for Instructed-No participants.  Activation of the cuneus was enhanced by cigarette cue 
presentation for Instructed-No participants, while cigarette and neutral conditions did not 
differ for Instructed-Yes participants.  Finally, cigarette-related activation of the RLPFC3 
was significantly lower than that elicited during neutral cue exposure for Instructed-Yes 
participants, while the opposite pattern (cigarette greater than neutral) was observed for 
Instructed-No participants.     
 
4.0 DISCUSSION 
 
 
The present study examined neural activity elicited by cigarette cue exposure in 
male cigarette smokers.  Several brain regions exhibited differential activation during 
cigarette relative to neutral stimulus presentation independent of whether or not 
participants expected to smoke during the study.  This distributed activation included 
                                                 
3 This double dissociation was significant for the more superior of the two RLPFC regions (z = 14 at local 
maximum).  The more ventral RLPFC region (z = -2 at local maximum) exhibited a trend towards 
significantly less activation for Instructed-Yes participants during cigarette relative to neural cue exposure 
[t(9) = 2.23, p = 0.053]. 
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regions associated with a diverse set of cognitive functions (DeLong, Crutcher, & 
Georgopoulos, 1985; Maddock, Garrett, & Buonocore, 2001; Mersulam, 1998), including 
brain areas implicated in the processing of visual (extrastriate cortex) and auditory 
(superior and middle temporal cortex) information, visuospatial integration (inferior 
parietal cortex), episodic and autobiographical memory retrieval (posterior cingulate 
gyrus), and control of movement (lentiform nucleus).  Activity in these areas likely 
reflects, in part, aspects of the cue exposure procedure employed in this study.  
Specifically, the neutral and drug-related stimulus configurations utilized in this study 
consisted of visual (e.g., sight of cue), tactile (holding and manipulating cue), and 
auditory (object identification and instructed smoking expectancy) stimulation.   
Although complex, results generally suggest that visuospatial and auditory 
processing resources were recruited to a greater extent by the cigarette cue than the 
neutral cue, as reflected by activation patterns in visual (lingual gyrus, cuneus), posterior 
parietal, and auditory (temporal) cortices (Mersulam, 1998).  The larger spatial extent of 
visual cortex recruited by neutral objects may reflect shifting gaze over a more extensive 
visual field (i.e., lack of sustained attention to neutral cues) or active inhibition of regions 
with receptive fields distal from attended to location of the cigarette during its 
presentation (Kastner, De Weerd, Desimone, & Ungerleider, 1998; Slotnick, 
Schwarzbach, & Yantis, 2003).  In constrast, we observed comparatively greater 
activation of regions associated with memory-related processing (parahippocampal gyrus, 
posterior cingulate; Duzel et al., 2003; Maddock et al., 2001) and control of movement 
(globus pallidus; DeLong et al., 1985) during neutral than cigarette cue exposure.  This 
could reflect more unconstrained mental processing involving retrieval (e.g., 
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daydreaming; Binder et al., 1999) during neutral cue presentation, while the cigarette cue 
was perhaps subject to vigilant processing associated with less episodic recall and more 
stable physical handling (e.g., holding the cigarette steadfast while staring at it).  
Alternatively, the neutral objects may have engaged greater memory resources and 
elicited more extensive physical manipulation than the cigarette cue because they were 
more novel to smokers than was the cigarette.    
Regardless of instructions, there was significantly greater activation of the rostral 
“affective division” of anterior cingulate cortex (Bush, Luu, & Posner, 2000; Vogt, 
Finch, & Olson, 1992) during cigarette than neutral cue exposure.  The anterior cingulate 
is the most frequently reported region of activation in studies of human drug craving and 
has been associated with exposure to cigarette (Brody et al., 2002), alcohol (Grüsser et 
al., in press; Myrick et al., 2004; Tapert et al., 2004; Tapert et al., 2003; Wrase et al., 
2002), cocaine (Childress et al., 1999; Garavan et al., 2000; Kilts et al., 2004; Kilts et al., 
2001; Wexler et al., 2001), and heroin (Daglish et al., 2001) cues.  As mentioned above, 
these studies did not directly manipulate perceived drug use opportunity.  Thus, the 
anterior cingulate appears to contribute to aspects of craving that do not depend upon 
drug use expectancy, such as assessment of the motivational value associated with drug 
cues based upon experience (Bush et al., 2000; See, 2002).4  The affective and 
motivational salience of drug cues as represented by anterior cingulate may reflect value 
                                                 
4 A recent study by Brody and colleagues (2004) found that cigarette smokers treated with buproprion 
exhibited less cue-elicited activation of the ACC than did untreated smokers.  However, the majority 
(approximately 70%) of treated participants did not achieve abstinence (i.e., they had “diminished usage”) 
and were not required to abstain before participation.  Thus, the extent to which this group anticipated the 
opportunity to smoke after the study is unclear, making it difficult to ascertain the impact of drug use 
expectancy versus other treatment-related factors (e.g., direct pharmacologic actions of buproprion) on 
ACC activation in this study.   This study stands in contrast to others classified as treatment studies in a 
review by Wilson et al. (2004), in which there was typically a minimal period of abstinence required before 
experimental sessions.    
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that is dependent upon an extensive drug use history and therefore this region may be less 
susceptible than are other brain areas to transient fluctuations as a function of perceived 
opportunity to consume. 
Of primary interest, the present study sought to examine the effects of perceived 
drug use opportunity on neural activity elicited by drug-related stimuli.  Several cortical 
areas exhibited cue-related activation that was modulated by perceived opportunity to 
smoke.  These included regions associated with unimodal and multimodal sensory 
processing (Mersulam, 1998), with the pattern of results suggesting that anticipating an 
opportunity to smoke resulted in relatively less attention to auditory and visual aspects of 
the craving stimulus complex than when such anticipation was not present.   
Based upon a review of the literature (Wilson et al., 2004), it was predicted that 
cue-elicited responses in OFC and DLPFC would be modulated by drug availability.  
These regions have been reported almost exclusively by studies recruiting active drug 
users (i.e., those not seeking treatment), suggesting that they may be more responsive to 
drug cues when future drug use is anticipated (Wilson et al., 2004).  Consistent with 
hypotheses, it was found that regions within OFC and DLPFC were sensitive to smoking 
expectancy.  However, rather than simply observing greater cue-elicited activation of 
OFC in participants expecting to smoke, it was observed that functional subdivisions 
within OFC were differentially influenced by drug availability.  Specifically, cigarette 
cue exposure was associated with significantly greater activation of VMPFC, a region 
closely related to the medial sector of OFC (Krawczyk, 2002), only when smoking was 
anticipated.  In contrast, we observed significantly less cigarette-related activation of 
VLPFC (i.e., lateral OFC) amongst participants that were expecting to smoke, while the 
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neutral and cigarette cue did not differ for participants that were not expecting to smoke.  
We also observed significantly less activation of DLPFC during cigarette than neutral cue 
exposure in participants expecting to smoke during the study, while neutral- and 
cigarette-related activity was similar in participants not expecting to smoke.  Thus, as 
previously noted (Wilson et al., 2004), the precise manner in which responses in OFC 
and DLPFC are affected by drug use expectancy are complex and dependent upon several 
factors, with patterns based upon coarse distinctions between treatment-seeking and 
actively using drug-addicted participants differing in important ways from those obtained 
via an explicit manipulation of drug use expectancy in active smokers. 
One factor that exerts significant influence over the effects of perceived drug use 
opportunity on cue-reactivity is the magnitude of delay anticipated until drug may be 
consumed.  For instance, cue-elicited responses of individuals expecting to smoke almost 
immediately differ significantly from those of participants expecting to wait only several 
seconds more before smoking (Sayette et al., 2003).  A second factor that may critically 
affect the impact of drug availability on cue-elicited responses is motivation regarding 
future drug use.  As mentioned, responses elicited by drug cues in drug-addicted 
individuals entering treatment may significantly differ from those produced in addicts 
with no intention of discontinuing drug use who are explicitly told that they can or cannot 
consume for a long period of time (Wertz & Sayette, 2001b).  In the former case, 
individuals do not intend to consume drugs because they are trying to quit (i.e., they are 
abstinence-seeking), while in the latter circumstance individuals desire to seek and 
administer drugs (i.e., they are abstinence-avoidant), but their ability to do so is 
determined by situational constraints (Tiffany, 1990).      
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In the present study, abstinence-avoidant smokers anticipating either a relatively 
short (40 seconds) or long (over 1 hour) delay were presented with one of their cigarettes.  
This paradigm resulted in significant cue-elicited increases in medial OFC and decreases 
in lateral OFC only amongst participants expecting to smoke soon.  It has been suggested 
that medial and lateral OFC have dissociable reward-related functions, with medial OFC 
subserving the representation and monitoring of reward values and lateral OFC recruited 
when established contingencies are altered and previously rewarded responses must be 
inhibited (Elliott, Dolan, & Frith, 2000).  The majority of previous studies reporting 
significant within- or between-group activation of OFC by drug cues found significant 
cue-evoked increases falling within the lateral portion of OFC in actively using 
participants that presumably anticipated having to wait an extended period of time (i.e., 
until leaving the experimental setting) before having the opportunity to consume drugs 
(Bonson et al., 2002; Brody et al., 2002; Myrick et al., 2004).  In contrast, Grant and 
colleagues (1996) found significant cue-evoked activation of medial OFC in active 
cocaine abusers who were told that they would be allowed to self-administer the cocaine 
presented to them following completion of experimental procedures.  With the exception 
of one study (Wrase et al., 2002), medial and lateral OFC activation have not been 
reported by studies recruiting participants enrolled in drug treatment. 
Taken together, these data suggest that medial OFC may contribute to explicit 
representation of drug use expectancy and processing of drug cues as predictors of 
reward (with a decrease in the need for lateral OFC mediated inhibitory control) when 
drug use is desired and expected to occur in a relatively short period of time (i.e., in 
abstinence-avoidant users expecting a short delay).  In contrast, lateral OFC may be 
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selectively recruited for the suppression of cue-elicited responses in abstinence-avoidant 
users anticipating a protracted delay preceding drug availability.  Finally, these 
subregions of OFC may not respond to drug cues in individuals motivated to avoid 
consumption (abstinence-seeking) and who therefore do not expect to use for an 
indefinite period of time.  
DLPFC, like OFC, responded differentially to the smoking-related and neutral cue 
only in smokers expecting an opportunity to smoke almost immediately, exhibiting less 
activation to the cigarette than the neutral stimulus.  As mentioned, the majority of 
studies recruiting active drug users have reported activation of DLPFC to be significantly 
increased by drug cues.  None of these studies informed participants that they would be 
able to use drugs without delay.  Studies employing treatment-seeking addicts – those 
presumably motivated to avoid future drug use and, thus, not anticipating the opportunity 
to consume – have generally failed to find significant cue effects in DLPFC.  Thus, it 
appears that processes mediated by DLPFC are recruited particularly in abstinence-
avoidant addicts that anticipate a delay between cue exposure and drug use.  In contrast, 
DLPFC resources appear not to be called upon (or are actively suppressed) in two distinct 
conditions: when abstinence-avoidant users anticipate almost no delay between cue 
presentation and drug consumption (as in the present study) or when those undergoing 
cue exposure are abstinence-seeking.  DLPFC plays a central role in reward-processing 
and decision-making, particularly when information must be maintained over a delay to 
guide behavior (Krawczyk, 2002).  One interesting possibility is that DLPFC mediated 
generation and maintenance of plans to obtain and consume drugs is augmented when 
drug use is desired but prevented by obstacles, while such planning (and thus, activation 
 25
of DLPFC) is not needed when drug use is not desired or when desire is high but no 
obstructions to consumption are faced.   
Results from this study yielded a third PFC region exhibiting activation that was 
modulated by smoking expectancy.  A double dissociation was found in RLPFC; 
specifically, activation of RLPFC elicited by cigarette cue exposure was significantly 
greater than that elicited by neutral stimuli for participants not expecting to smoke during 
the study (i.e., Instructed-No group), while neutral cues elicited greater activation than 
did the cigarette for those expecting to smoke (Instructed-Yes group).  It has been 
suggested that rostrolateral PFC is selectively involved in the evaluation of self-generated 
information (e.g., information that must be inferred; Christoff & Gabrieli, 2000; 
Christoff, Ream, Geddes, & Gabrieli, 2003).  This suggests that Instructed-No 
participants preferentially engaged in processing of internally-generated information 
during drug cue exposure, whereas this epoch was not associated with such processing 
(or even a suppression of such activity) for Instructed-Yes participants.  For participants 
not expecting to smoke soon, this internally-generated information may have been related 
to future drug seeking (e.g., generating or evaluating plans to smoke after the study).  
Such processing may have been unnecessary for those holding a cigarette that they 
expected to smoke almost immediately, consistent with the observation of cue-elicited 
decreases in DLPFC activation. 
The primary aim of this study was to examine the effects of smoking expectancy 
on the neural response to a cigarette cue.  It was previously reported that treatment status, 
a proxy for drug use opportunity, appears to significantly influence responses to drug-
related stimuli in the prefrontal cortex (Wilson et al., 2004).  The present study, which 
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found a significant expectancy effects in OFC and DLPFC, provides additional evidence 
that drug use expectancy can affect the way in which drug-related stimuli are processed 
in these regions.  
While promising, these initial findings should be interpreted cautiously because of 
several limitations of this study.  Interaction effects were obtained at a fairly liberal 
statistical threshold by conventional neuroimaging standards.  Thus, while confidence in 
these results is strengthened by the identification of a priori regions of interest, these data 
must be considered preliminary and in need of replication.  In addition, while OFC and 
DLPFC were successfully identified as regions modulated by smoking expectancy, the 
observed pattern of effects were fairly complex.  I have attempted to account for both 
points of convergence and points of discrepancy between the current data set and data 
from a prior review (Wilson et al., 2004) through a consideration of factors (e.g., delay, 
motivation regarding future drug use) that may significantly affect how perceived 
opportunity influences cue-reactivity.  Nevertheless, these interpretations await direct 
empirical investigation.  Finally, because the current study recruited only male smokers, 
it is unclear whether similar effects would be observed in female smokers.  For instance, 
research demonstrates that male and female smokers differ in their response to smoking-
related stimuli and nicotine administration (Perkins et al., 2001).   
Despite these limitations, these findings highlight the importance of perceived 
drug use opportunity as an area of investigation for addiction researchers using functional 
neuroimaging to study cue reactivity.  Further, these data generate intriguing and testable 
hypotheses regarding the role of subregions of PFC in drug craving and addiction.  
Contemporary neurobiological models of addiction and craving emphasize decreased 
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inhibitory control as a consequence of adulterations to PFC function produced by chronic 
drug use (Goldstein & Volkow, 2002; Jentsch & Taylor, 1999; London et al., 2000).  The 
present results raise the possibility that, in addition to such inhibitory deficits (i.e., 
resulting in being “overcome” by urge), the state of addiction also can be associated with 
the active recruitment of different cognitive processes mediated by regions of PFC in the 
support of drug acquisition and consumption.  On the one hand, medial OFC may 
contribute to explicit representation of drug use expectancy and processing of drug cues 
as predictors of reward, with a decrease in the need for lateral OFC mediated inhibitory 
control, when presented concomitant with proximally anticipated consumption.  On the 
other hand, activation of PFC regions supporting complex cognition and planning 
(rostrolateral and dorsolateral PFC) may ensue in the face of drug cue exposure when use 
is delayed or otherwise prevented by obstacles.   
More generally, chronic drug use may sharpen the efficiency with which the 
addicted system recruits resources in the services of drug seeking and acquisition.  
Indeed, it has been found that smokers lacking proximal drug use expectancy generated 
more positive, but not negative, aspects of smoking during craving, perhaps because 
drug-use promoting information is selectively retrieved from or actively maintained in 
memory (Sayette & Hufford, 1997).  Moreover, attentional biases to smoking related 
stimuli are enhanced (Wertz & Sayette, 2001a) and latency to attempt to access drug cues 
is decreased (Carter & Tiffany, 2001) as perceived drug use opportunity increases.  This 
suggests that the salience and motivational significance of drug cues is augmented as 
drug use is approached.  Taken together, evidence suggests that the route by which drug 
cue exposure influences neural and behavioral response systems is complex and context-
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dependent.  Further research and theory attempting to explicate the role of PFC and other 
regions in craving and drug use will be enhanced by considering the various ways in 
which chronic drug use may render the brain more efficient at utilizing available 
resources to promote further drug intake across contexts.  
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APPENDIX A: 
 
 
 
Object Presentation Instructions 
 
Neutral 1 (both groups): 
“Now you will be holding a notepad.” 
 
Neutral 2 (both groups): 
"Now you will be holding a plastic golf ball” 
 
Neutral 3 (both groups): 
“Now you will be holding a roll of tape.” 
 
Cigarette (Instructed-Yes): 
"Now you will be asked to hold one of your cigarettes.  In 40 seconds, you will be 
  removed from the scanner and will be allowed to smoke the cigarette you are 
holding.  Although it took a few minutes to be placed in the scanner, it will only 
take a few seconds to be removed from the scanner and walk down the hall to a 
room where you can smoke."  
 
Cigarette (Instructed-No): 
"Now you will be asked to hold one of your cigarettes.  In 40 seconds, you  
will be removed from the scanner but you WILL NOT be allowed to smoke the  
cigarette you are holding.  You will have to wait until the end of the study to  
smoke.  Although it took a few minutes to be placed in the scanner, it will only  
take a few seconds to be removed from the scanner.  
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Tables 
Table 1.  Activation of DLPFC and OFC During Drug-Cue Exposure. 
 
               Study    
Imaging 
Modality 
Addictive 
Substance 
 
Drug cue 
 
DLPFC 
 
OFC 
Drug users currently not seeking treatment 
   
 Bonson et al. (2002) PET Cocaine Video, Script, Paraph X X 
 Brody et al. (2002) PET Cigarette Video, Tactile  X 
 Due et al. (2002) fMRI Cigarette Pictures X  
 Garavan et al. (2000) fMRI Cocaine Video X  
 George et al. (2001) fMRI Alcohol Pictures, Gust X  
 Grant et al. (1996) PET Cocaine Video, Paraph X X 
 Maas et al. (1998) fMRI Cocaine Video X NA 
 Myrick et al. (2004) fMRI Alcohol Pictures, Gust  X 
 Tapert et al. (2003) fMRI Alcohol Pictures  X 
 Tapert et al. (2004) fMRI Alcohol Words X  
 Wang et al. (1999) PET Cocaine Script, Tactile  X 
Drug users currently seeking treatment    
 Braus et al. (2001) PET Alcohol Video   
 Childress et al. (1999) PET Cocaine Video   
 Daglish et al. (2001) PET Opiate Script   
 Grüsser et al. (in press) fMRI Alcohol Pictures X  
 Kilts et al. (2001) PET Cocaine Script   
 Modell et al. (1995) SPECT Alcohol Gust, Olfactory   
 Schneider et al. (2001) fMRI Alcohol Olfactory   
 Sell et al. (1999) PET Opiate Video, Drug   
 Wexler et al. (2001) fMRI Cocaine Video   
 Wrase et al. (2002) fMRI Alcohol Pictures X X 
 
X = significant within- or between-group activation, NA = not assessed.  Abbreviations: OFC, orbitofrontal cortex; DLPFC, 
dorsolateral prefrontal cortex;  fMRI, functional magnetic resonance imaging; PET,  positron emission tomography; SPECT, 
Single photon emission computed tomography; Drug, drug administration; Gust, gustatory stimulation with drug-related taste; 
Olfactory, olfactory stimulation with drug-related scents; Paraph, visual presentation of drug paraphernalia; Pictures, visual 
presentation of drug-related pictures; Tactile, tactile stimulation with drug cues; Script, drug-related craving induction 
script/interview; Video, audiovisual presentation of drug-related scenes; Words, visual presentation of drug-related words.    
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Table 2.  Participant Demographic Characteristics and Self-Reported Urge. 
 Instructed-Yes Instructed-No 
 
Age 
 
24.1 (4.3) 
 
25.3 (5.9) 
 
Cigarettes/day 
 
21.3 (2.2) 
 
22.0 (3.4) 
 
Years smoking 
 
7.8 (1.9) 
 
8.1 (4.8) 
 
Quit attempts 
 
3.4 (4.9) 
 
1.0 (1.2) 
 
Education 
 
13.4 (1.7) 
 
13.1 (1.3) 
 
Urge #1 
 
59.5 (20.6) 
 
61.5 (23.9) 
 
Urge #2 
 
60.5 (24.1) 
 
62.2 (22.8) 
 
Urge #3 
 
70.5 (25.1) 
 
72.0 (27.1) 
 
Urge #4 
 
76.5 (20.1) 
 
72.3 (27.1) 
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Table 3.  Regions Exhibiting a Main Effect of Cue. 
 Broadmann’s Talairach coordinates Average 
Anatomical Region Area x y z F ratio 
Cigarette > Neutral        
   L Superior occipital g  19 -41 -77 29 14.06 
   R Posterior cingulate g 23 4 -43 29 16.36 
   L Inferior parietal lobule 39 -54 -68 24 12.59 
   L Ant cing / Superior frontal g  32 -4 43 8 15.02 
   L Middle occipital g 18 -26 -96 5 16.85 
   L Superior / middle temporal g 21 -50 -23 -1 23.81 
   R Cuneus  18 23 -100 -1 12.91 
   R Superior / middle temporal g 21 56 -28 -3 20.99 
   R Fusiform g  23 -96 -12 11.24 
Neutral > Cigarette      
   L Cingulate g 24 -14 -14 39 11.33 
   R Cingulate g 24 20 -17 38 13.03 
   L Cingulate g 31 -19 -34 39 11.4 
   L Precuneus 7 -14 -74 35 11.77 
   L Thalamus  -7 -34 12 13.07 
   R Lentiform nucleus  21 -9 7 20.09 
   L Lentiform nucleus  -19 -13 5 15.54 
   R Middle occipital g 19 31 -65 6 11.6 
   L Lingual g / cuneus  17/18/19 -20 -78 5 15.46 
   L Insula 13 -40 -7 -2 12.9 
   R Thalamus  4 -10 0 13.05 
 
Brodmann’s areas (BA) and stereotaxic coordinates are given for local maxima of 
activation cluster in Talairach and Tournoux (1988) atlas space.  Abbrebiation: g, gyrus.   
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Table 4.  Regions Exhibiting a Significant Instruction Set by Cue Interaction. 
 Brodmann’s    Talairach coordinates Average 
Anatomical Region Area Y N  x y Z F ratio 
 
R Middle frontal g (DLPFC)  9 ? ns  30 35 37 12.05 
 
L Cuneus 19 ns ?  -8 -96 31 16.27 
 
L Inferior frontal g (DLPFC)  9 ? ns  -48 6 25 12.6 
 
R Middle frontal g (DLPFC) 46 ? ns  46 18 21 9.31 
 
R Precentral g 6 ? ns  70 4 16 10.64 
 
R Superior frontal g (RLPFC) 10 ns ?  35 59 14 10.39 
 
L Middle temporal g 21 ? ns  -67 -7 -1 12.41 
 
R Middle frontal g (RLPFC) 10 ? ?  37 52 -2 9.88 
 
L Inferior frontal g (VLPFC) 47 ? ns  -47 27 -5 9.88 
 
R Superior temporal g 22 ? ns  48 7 -6 10.32 
 
L Inferior/middle occipital g 19/18 ? ns  -36 -68 -6 11.44 
 
L Superior frontal g (VMPFC) 10 ? ns  -8 57 -7 9.22 
 
L Parahippocampal g    ? ns  -23 -16 -10 10.31 
   
Brodmann’s areas (BA) and stereotaxic coordinates are given for local maxima of activation cluster in 
Talairach and Tournoux (1988) atlas space.  Abbreviations: DLPFC, dorsolateral prefrontal cortex; g, 
gyrus; N, Instructed-No group; ns, not significant; RLPFC, rostrolateral prefrontal cortex; VLPFC, 
ventrolateral prefrontal cortex; VMPFC, ventromedial prefrontal cortex; Y, Instructed-Yes group. 
? = significantly greater activation during cigarette relative to neutral cue exposure, ? = significantly 
greater activation during neutral relative to cigarette cue exposure. 
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Figure Legends 
Figure 1.  Lateral (left), mid-saggital (middle) and coronal (right) sections of the brain 
illustrating neural regions that have been implicated in cue-elicited craving.  
Abbreviations: DLPFC, dorsolateral prefrontal cortex; OFC, orbitofrontal cortex; ACC, 
anterior cingulate cortex; AMG, amygdala.  (Images modified from Sylvius: 
Fundamentals of Human Neural Structure, S. Mark Williams, Sinauer Associates, Inc. 
Sunderland MA). 
 
Figure 2.  Schematic diagram of the cue exposure task.  During each cue exposure run, 
subjects completed the following sequence: an initial 48 second resting baseline epoch 
during which no objects were held, presentation of first object for a period of 74 seconds, 
a second 74 second resting baseline epoch, second object presented for 74 seconds.  
Neutral object 1 (notepad) and neutral object 2 (plastic golf ball) were presented during 
run 1.  Neutral object 3 (roll of electrical tape) and cigarette were presented during run 2.  
 
Figure 3.  Mean urge to smoke ratings.   
 
Figure 4.  Regions exhibiting a significant main effect of cue.  Regions in which activity 
associated with cigarette cue exposure was greater than neutral cue exposure are depicted 
in red; the reverse (neutral greater than cigarette) are depicted in blue.  Images are right-
left reversed.       
 
Figure 5.  A:  Regions exhibiting a significant instruction set by cue interaction.  
Abbreviations: DLPFC, dorsolateral prefrontal cortex; Inf, inferior; L, left; Parahipp, 
parahippocampal gyrus; R, right; RLPFC, rostrolateral prefrontal cortex; Sup, superior; 
Temp, temporal gyrus; VLPFC, ventrolateral prefrontal cortex; VMPFC, ventromedial 
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prefrontal cortex.  Images are right-left reversed.  B:  Graphs plot percent signal change 
during cigarette cue exposure relative to neutral cue exposure.  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 1 
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